Related Experiment Video
Updated: Aug 21, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy
1Serviço de Saude-PCARP, Ribeirão Preto, Brazil.
Insights
Chronic Chagas' heart disease patients experienced a worse clinical course compared to non-Chagas dilated cardiomyopathy patients. This difference in outcomes for Chagas heart disease is linked to unique electrocardiographic and morphological features.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Chagas' heart disease, caused by Trypanosoma cruzi, is a significant cause of cardiomyopathy in endemic regions.
- Dilated cardiomyopathy encompasses various etiologies, including hypertension, idiopathic, and ischemic causes.
- Comparing clinical outcomes is crucial for understanding disease progression and management.
Purpose of the Study:
- To compare the clinical course of chronic Chagas' heart disease with non-Chagas dilated cardiomyopathy.
- To identify differences in mortality and causes of death between the two groups.
- To explore potential factors contributing to disparities in clinical outcomes.
Main Methods:
- Prospective follow-up of 125 patients (75 Chagasic, 50 non-Chagasic) over three years.
- Comprehensive evaluation including clinical assessment, serological tests, ECG, chest X-ray, and echocardiography.
- Analysis of mortality rates and causes of death.
Main Results:
- A significantly higher mortality rate was observed in Chagasic patients (23%) compared to non-Chagasic patients (6%) (P = 0.02).
- Sudden cardiac death and pump failure were the primary causes of mortality in Chagas' heart disease.
- Non-Chagasic patients predominantly had hypertensive or idiopathic dilated cardiomyopathy.
Conclusions:
- Patients with chronic Chagas' heart disease exhibit a poorer clinical course than those with non-Chagasic dilated cardiomyopathy.
- Electrocardiographic and morphological peculiarities in Chagas' heart disease likely contribute to worse outcomes.
- Further research into these specific features may guide improved management strategies for Chagas' heart disease.
Abstract:
This investigation was carried out to compare the clinical course of patients with chronic Chagas' heart disease with that of patients with dilated cardiomyopathy. A total of 125 patients (75 chagasic and 50 nonchagasic) prospectively followed up at the Cardiomyopathy clinic of Santa Casa Hospital from January 1990 to June 1993 entered the study. Patients underwent clinical history, physical examination, serological tests, resting electrocardiogram, chest X-ray and two-dimensional echocardiography. In nonchagasic patients, hypertensive cardiomyopathy was found in 17 of 50 (34%) patients, idiopathic dilated cardiomyopathy in 16 (32%), the association of hypertension and coronary artery disease in 12 (24%) and ischemic cardiomyopathy in two (4%). Twenty-one (23%) chagasic and three (6%) nonchagasic patients died during the study period (P = 0.02). Sudden cardiac death occurred in eight (38%) chagasic patients, pump failure death was detected in 10 (47%) and the mode of death could not be determined in three (14%) patients with chronic Chagas' heart disease. Thus, patients with chronic Chagas' heart disease have a clinical course worse than that of patients with nonchagasic dilated cardiomyopathy. This fact may be ascribed to the electrocardiographic and morphological peculiarities usually found in chronic Chagas' heart disease.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
American Trypanosomiasis

